Skip to main content

Fisher, Evotec

Premium

Fisher's Q3 Revenues Grow 13 Percent as Profit More Than Doubles

Fisher Scientific last week reported a 13-percent increase in revenues, and more than doubled its net income for the three months ended Sept. 30.

Fisher's revenues for the third quarter rose to $1.4 billion from $1.26 billion in the same period a year ago.

Net income also surged to $94 million, or $0.77 per basic share, from $36 milllion, or $0.36 per basic share in the year-ago period.

Fisher Scientific had approximately $189.2 million in cash and cash investments as of Sept. 30.

The company did not report R&D expenditures for the quarter.

In September, Fisher acquired HCS shop Cellomics for $49 million (see CBA News, 9/12/2005).


Evotec Tech Sees Losses Increase by
43 Percent amid 54-Percent Revenue Growth

Evotec Technologies, the technology division of Evotec OAI, last week reported a 54-percent growth in third-party revenue, but saw its net losses increase by 43 percent for the third quarter ended Sept. 30.

Evotec Tech's third-party revenues for Q3 rose to €3.96 million ($4.64 million), from €2.58 million in the year-ago period.

The division posted a net loss of €1.95 million in Q3, compared to €1.37 million in Q3 2004. The Tech division spent €1.5 million on R&D in Q3, on par with the amount it spent in the same quarter last year.

Evotec Tech is a subsidiary of German drug-discovery firm Evotec OAI, and counts the Opera confocal plate reader and EVOScreen integrated high-throughput screening platform among its offerings.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.